Increased Cardiometabolic Risk and Worsening Hypoxemia at High Altitude

High Altitude Medicine and Biology

Volumn 17, Issue 2, 2016, Pages 93-100

  Miele, Catherine H ^a   Schwartz, Alan R ^a   Gilman, Robert H ^b   Pham, Luu ^a   Wise, Robert A ^a   Davila Roman, Victor G ^c   Jun, Jonathan C ^a   Polotsky, Vsevolod Y ^a   Miranda, J Jaime ^d,e   Leon Velarde, Fabiola ^e   Checkley, William ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Altitude; Diabetes; Hypoxemia; Insulin resistance; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH SENSITIVITY C REACTIVE PROTEIN; OXYHEMOGLOBIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGE; ALTITUDE DISEASE; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; ERYTHROCYTOSIS; FEMALE; HUMAN; INSULIN RESISTANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXYGEN SATURATION; PERU; PRIORITY JOURNAL; REST; RISK ASSESSMENT; ALTITUDE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DISEASE COURSE; HYPOXIA; MIDDLE AGED; OXIMETRY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYCYTHEMIA; RISK FACTOR; STATISTICAL MODEL;

ADULT; ALTITUDE; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOXIA; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIMETRY; OXYHEMOGLOBINS; PERU; POLYCYTHEMIA; REST; RISK FACTORS;

EID: 84973901476     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2015.0084     Document Type: Article

References (50)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, and Smith SC, Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
2. Azevedo JL, Jr., Carey JO, Pories WJ, Morris PG, and Dohm GL. (1995). Hypoxia stimulates glucose transport in insulinresistant human skeletal muscle. Diabetes 44:695-698.
3. Baracco R, Mohanna S, and Seclén S. (2007). A comparison of the prevalence of metabolic syndrome and its components in high and low altitude populations in peru. Metab Syndr Relat Disord 5:55-62.
4. Brotman DJ, and Girod JP. (2002). The metabolic syndrome: a tug-of-war with no winner. Cleve Clin J Med 69:990-994.
5. Chirinos DA, Morey-Vargas OL, Goldberg RB, Chirinos JA, and Medina-Lezama J. (2013). Metabolic syndrome in Andean populations. Global Heart 8:349-354. e1.
6. Chou SW, Chiu LL, Cho YM, Ho HY, Ivy JL, Ho CF, and Kuo CH. (2004). Effect of systemic hypoxia on GLUT4 protein expression in exercised rat heart. Jpn J Physiol 54:357-363.
7. De Ferrari A, Miranda JJ, Gilman RH, Dávila-Román VG, León-Velarde F, Rivera-Ch M, Huicho L, Bernabé-Ortiz A, Wise RA, Checkley W; CRONICAS Cohort Study Group (2014). Prevalence, clinical profile, iron status and subject-specific traits for excessive erythrocytosis in Andean adults living permanently at 3825 meters above sea level. Chest 145:1327-1336.
8. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, and Poirier P. (2008). Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039-1049.
9. Drager LF, Jun JC, and Polotsky VY. (2010). Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 24:843-851.
10. Grundy SM, Hansen B, Smith SC, Jr., Cleeman JI, and Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. (2004). Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:433-438.
11. He Q, Gao Z, Yin J, Zhang J, Yun Z, and Ye J. (2011). Regulation of HIF-1alpha activity in adipose tissue by obesityassociated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab 300:E877-E885.
12. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, and Shimomura I. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911.
13. Howe LD, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, Patel R, Webb EA, Lawlor DA, and Hargreaves JR. (2012). Measuring socio-economic position for epidemiological studies in low-and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol 41:871-886.
14. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, et al. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
15. Jones RL. (2006). The effects of body mass index on lung volumes. Chest 130:827-833.
16. Jun JC, Shin MK, Devera R, Yao Q, Mesarwi O, Bevans-Fonti S, and Polotsky VY. (2014). Intermittent hypoxia-induced glucose intolerance is abolished by alpha-adrenergic blockade or adrenal medullectomy. Am J Physiol Endocrinol Metab 307:E1073-E1083.
17. Kahn BB, Alquier T, Carling D, and Hardie DG. (2005). AMPactivated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
18. Kannel WB, Hubert H, and Lew EA. (1983). Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 105:311-315.
19. Lee HM, Truong ST, and Wong ND. (2011). Evidence of lung function for stratification of cardiovascular disease risk. Korean Circ J 41:171-174.
20. León-Velarde F, Maggiorini M, Reeves JT, et al. (2005). Consensus statement on chronic and subacute high altitude disease. High Alt Med Biol 6:147-157.
21. Luks AM, and Swenson ER. (2011). Pulse oximetry at high altitude. High Alt Med Biol 12:109-119.
22. Mackenzie R, Maxwell N, Castle P, Brickley G, and Watt P. (2011). Acute hypoxia and exercise improve insulin sensitivity (S(I) (2)) in individuals with type 2 diabetes. Diabetes Metab Res Rev 27:94-101.
23. Mackenzie R, Maxwell N, Castle P, Elliott B, Brickley G, and Watt P. (2012). Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab 97:E546-E555.
24. Malaga G, Zevallos-Palacios C, Lazo M de LA, and Huayanay C. (2010). High frequency of dyslipidemia and impaired fasting glycemia in a high altitude Peruvian population. Rev Peru Med Exp Salud Publica 27:557-561.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
26. Medina-Lezama J, Pastorius CA, Zea-Diaz H, Bernabe-Ortiz A, Corrales-Medina F, Morey-Vargas OL, Chirinos DA, Munoz-Atahualpa E, Chirinos-Pacheco J, and Chirinos JA; On behalf of the PREVENCION Investigators. (2010). Optimal Definitions for Abdominal Obesity and the Metabolic Syndrome in Andean Hispanics: The PREVENCION Study. Diabetes Care 33:1385-1388.
27. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, and Wanger J; ATS/ERS Task Force. (2005). Standardisation of spirometry. Eur Respir J 26:319-338.
28. Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, and Checkley W; CRONICAS Cohort Study Group. (2012). Addressing geographical variation in the progression of noncommunicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open 2:e000610.
29. Monge C. (1942). Life in the andes and chronic mountain sickness. Science 95:79-84.
30. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, and Eisenberg MJ. (2010). The metabolic syndrome and cardiovascular risk. J Am Coll Cardiol 56:1113-1132.
31. Ortega-Saenz P, Pardal R, Levitsky K, Villadiego J, Munoz-Manchado AB, Duran R, Bonilla-Henao V, Arias-Mayenco I, Sobrino V, Ordóñez A, Oliver M, Toledo-Aral JJ, and López-Barneo J. (2013). Cellular properties and chemosensory responses of the human carotid body. J Physiol 591:6157-6173.
32. Palmer BF, and Clegg DJ. (2014). Ascent to altitude as a weight loss method: the good and bad of hypoxia inducible factor activation. Obesity 22:311-317.
33. Peltonen GL, Scalzo RL, Schweder MM, Larson DG, Luckasen GJ, Irwin D, Hamilton KL, Schroeder T, and Bell C. (2012). Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humans. J Physiol 590: 2801-2809.
34. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, and O'Donnell CP. (2004). Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253-264.
35. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, and Stocks J. (2012). Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40:1324-1343.
36. Roberts AC, Butterfield GE, Cymerman A, Reeves JT, Wolfel EE, and Brooks GA. (1985). Acclimatization to 4, 300-m altitude decreases reliance on fat as a substrate. J Appl Physiol 81:1762-1771.
37. Ryan S, Taylor CT, and McNicholas WT. (2005). Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667.
38. Sakagami H, Makino Y, Mizumoto K, Isoe T, Takeda Y, Watanabe J, Fujita Y, Takiyama Y, Abiko A, and Haneda M. (2014). Loss of HIF-1alpha impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells. Am J Physiol Endocrinol Metab 306:E1065-E1076.
39. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD, and Heiss G. (2003). Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol 158:1171-1181.
40. Semenza GL. (1999). Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
41. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Nafstad P, and Bjertness E. (2013). Prevalence of metabolic syndrome and common metabolic components in high altitude farmers and herdsmen at 3700m in Tibet. High Alt Med Biol 14:37-44.
42. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Thelle DS, and Bjertness E. (2010). Obesity in Tibetans aged 30-70 living at different altitudes under the north and south faces of Mt. Everest. Int J Environ Res Public Health 7:1670-1680.
43. Shin MK, Yao Q, Jun JC, Bevans-Fonti S, Yoo D-Y, Han W, Mesarwi O, Richardson R, Fu YY, Pasricha PJ, Schwartz AR, Shirahata M, and Polotsky VY. (2014). Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia. J Appl Physiol 117:765-776.
44. Vargas E, and Spielvogel H. (2006). Chronic mountain sickness, optimal hemoglobin, and heart disease. High Alt Med Biol 7:138-149.
45. Whayne TF, Jr. (2014). Cardiovascular medicine at high altitude. Angiology 65:459-472.
46. Wheaton WW, and Chandel NS. (2011). Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol 300: C385-C393.
47. WHO STEPwise Approach to Survalance (STEPS). Available at www. whoint/chp/steps/manual/en/indexhtml (last accessed May 31, 2014).
48. Wilson PW, D'Agostino RB, Parise H, Sullivan L, and Meigs JB. (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072.
49. Woolcott OO, Castillo OA, Gutierrez C, Elashoff RM, Stefanovski D, and Bergman RN. (2014). Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States. Obesity 22:2080-2090.
50. World Health Organization. Cardiovascular diseases (CVDs). Available at www. who. int/mediacentre/factsheets/fs317/en/(last accessed January 2015).